These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 6271681

  • 1. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
    Dix RD, Pereira L, Baringer JR.
    Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
    [Abstract] [Full Text] [Related]

  • 2. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL, Lukig ML, Liew FY.
    J Exp Med; 1985 Oct 01; 162(4):1304-18. PubMed ID: 2995536
    [Abstract] [Full Text] [Related]

  • 3. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL, Duncan BE, Raybould TJ, Watson DH.
    J Gen Virol; 1985 May 01; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [Abstract] [Full Text] [Related]

  • 4. Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
    Dix RD, Mills J.
    J Med Virol; 1985 Sep 01; 17(1):9-18. PubMed ID: 2995573
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein gB of herpes simplex virus expresses type-common and type-specific antigenic determinants in vivo.
    Dix RD.
    J Med Virol; 1990 Mar 01; 30(3):192-5. PubMed ID: 1692872
    [Abstract] [Full Text] [Related]

  • 6. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.
    Balachandran N, Bacchetti S, Rawls WE.
    Infect Immun; 1982 Sep 01; 37(3):1132-7. PubMed ID: 6290390
    [Abstract] [Full Text] [Related]

  • 7. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection.
    Rector JT, Lausch RN, Oakes JE.
    Infect Immun; 1982 Oct 01; 38(1):168-74. PubMed ID: 6292092
    [Abstract] [Full Text] [Related]

  • 8. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH, Oakes JE, Lausch RN.
    Invest Ophthalmol Vis Sci; 1993 Jul 01; 34(8):2460-8. PubMed ID: 8392037
    [Abstract] [Full Text] [Related]

  • 9. Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread.
    McKendall RR, Klassen T, Baringer JR.
    Infect Immun; 1979 Feb 01; 23(2):305-11. PubMed ID: 217828
    [Abstract] [Full Text] [Related]

  • 10. Passive immunization of mice with monoclonal antibodies to glycoprotein gB of herpes simplex virus.
    Kino Y, Eto T, Ohtomo N, Hayashi Y, Yamamoto M, Mori R.
    Microbiol Immunol; 1985 Feb 01; 29(2):143-9. PubMed ID: 2989659
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K, Tomaras GD, Jegaskanda S, Moody MA, Liao HX, Goodman KN, Berman PW, Rerks-Ngarm S, Pitisuttithum P, Nitayapan S, Kaewkungwal J, Haynes BF, Cohen JI.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28701403
    [Abstract] [Full Text] [Related]

  • 12. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 13. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC.
    J Virol; 1985 Dec 01; 56(3):930-7. PubMed ID: 2415719
    [Abstract] [Full Text] [Related]

  • 14. Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans.
    Cairns TM, Huang ZY, Whitbeck JC, Ponce de Leon M, Lou H, Wald A, Krummenacher C, Eisenberg RJ, Cohen GH.
    J Virol; 2014 Nov 01; 88(21):12612-22. PubMed ID: 25142599
    [Abstract] [Full Text] [Related]

  • 15. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1.
    Pereira L, Klassen T, Baringer JR.
    Infect Immun; 1980 Aug 01; 29(2):724-32. PubMed ID: 6260657
    [Abstract] [Full Text] [Related]

  • 16. Effects of monoclonal antibodies directed against herpes simplex virus-specified glycoproteins on the generation of virus-specific and H-2-restricted cytotoxic T-lymphocytes.
    Sethi KK.
    J Gen Virol; 1983 Sep 01; 64 (Pt 9)():2033-7. PubMed ID: 6310041
    [Abstract] [Full Text] [Related]

  • 17. Competitive inhibition by human sera of mouse monoclonal antibody binding to glycoproteins C and D of herpes simplex virus types 1 and 2.
    Ross C, Glorioso J, Sacks S, Lavery C, Rawls WE.
    J Virol; 1985 Jun 01; 54(3):851-5. PubMed ID: 2582149
    [Abstract] [Full Text] [Related]

  • 18. Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody.
    Arvin AM, Koropchak CM, Yeager AS, Pereira L.
    Infect Immun; 1983 Apr 01; 40(1):184-9. PubMed ID: 6832831
    [Abstract] [Full Text] [Related]

  • 19. Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID).
    Minagawa H, Sakuma S, Mohri S, Mori R, Watanabe T.
    Arch Virol; 1988 Apr 01; 103(1-2):73-82. PubMed ID: 2850780
    [Abstract] [Full Text] [Related]

  • 20. The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.
    Eberle R, Mou SW, Zaia JA.
    J Med Virol; 1985 Jun 01; 16(2):147-62. PubMed ID: 2409225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.